Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population
Loading...
Files
Accepted Version
Date
2021-03-24
Authors
Abdouh, Ismail
Porter, Stephen
Fedele, Stefano
Elgendy, Nadia
Aboalshamat, Khalid
Babkair, Hamzah Ali
Ní Riordain, Richeal
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons, Inc.
Published Version
Abstract
Background: The objective of the present study was to identify the impact of systemic sclerosis (SSc) upon oral health-related quality of life (OHRQoL) of affected individuals resident in the UK.
Methods: A total of 100 patients and their partners or carers were invited to complete questionnaires regarding the impact of SSc on quality of life and psychological well-being using valid and reliable patient-reported outcome measures (OHIP-14, MHISS, OIDP, MDAS and HADS). A total of 50 patients with SSc and 18 partners or carers who acted as controls returned the completed questionnaires. Statistical analyses were performed for comparisons of different variables.
Results: All the mean scores of OHIP-14 (SSc [16.5 ± 12.4] Vs controls [6.06 ± 7.6, p = 0.001]) and MHISS components were significantly higher in patients than those of control group (SSc [21.26 ± 12] Vs controls [4.8 ± 7.3, p < 0.0001]). Majority of OIDP mean scores were significantly worse in patients compared with controls [SSc (10 ± 8.7) Vs controls (1.72 ± 3.4, p < 0.0001)]. The mean of total MDAS [SSc (11.7 ± 5.3) Vs controls (9.5 ± 4.4)] and HADS scores were higher in patients compared to controls (SSc depression [4.8 ± 3.3] and anxiety [6 ± 4.6] Vs controls [3.7 ± 3.1] [4.7 ± 3.9]).
Conclusions: Although the present study is limited by the low response rate and its cross-sectional design, present results highlighted that systemic sclerosis has a negative impact on OHRQoL of the affected individuals; hence, the evaluation of associated psychological impact including anxiety and depression symptoms is needed to better understand, monitor and evaluate the disease comorbidity in patients with SSc.
Description
Keywords
Oral health , Quality of life , Systemic sclerosis
Citation
Abdouh, I., Porter, S., Fedele, S., Elledge, N., Aboalshamat, K., Babkair, H. A. and Ní Riordain, R. (2021) 'Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population', Journal of Oral Pathology & Medicine, 50 (8), pp. 812-819. doi: 10.1111/jop.13177
Copyright
© 2021, John Wiley & Sons, Inc. This is the peer reviewed version of the following article: Abdouh, I., Porter, S., Fedele, S., Elledge, N., Aboalshamat, K., Babkair, H. A. and Ní Riordain, R. (2021) 'Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population', Journal of Oral Pathology & Medicine, 50 (8), pp. 812-819. doi: 10.1111/jop.13177, which has been published in final form at https://doi.org/10.1111/jop.13177. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions